Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology
First Claim
Patent Images
1. A compound selected from compounds capable of binding to hormone receptors and in that it comprises a nitrogen monoxide-donor nitric ester group, with the exception of estradiol substituted in the 11- and/or 17-position with a nitric ester group.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention concerns compounds capable of being fixed on hormone receptors and having a nitrogen monoxide donor group, their use for preventing premature births, increasing cervical-dilatation, for use in hormone substitution therapy as anti-hypertensive drug and their therapeutic use for preparing a medicine for use in obstetrics and gynecology.
-
Citations
42 Claims
- 1. A compound selected from compounds capable of binding to hormone receptors and in that it comprises a nitrogen monoxide-donor nitric ester group, with the exception of estradiol substituted in the 11- and/or 17-position with a nitric ester group.
-
22-33. -33. (canceled)
Specification